Analysis of time to response to chemotherapy in 316 metastatic breast cancer patients

P. Pronzato, G. Bertelli, G. Gardin, A. Rubagotti, P. F. Conte, R. Rosso

Research output: Contribution to journalArticlepeer-review


Chemotherapy is a major tool for metastatic breast cancer treatment. In this study, a series of 316 patients have been analyzed to evaluate the time needed to reach tumor response by means of combination chemotherapy. Twenty-five percent of patients responded within 3 months and virtually all responses occurred within 7.5 months. The time curves of response (any) and best response are superimposable. A subset analysis has shown that the following pretreatment characteristics predict a significantly longer time to response: prior exposure to adjuvant chemotherapy, nodal positivity at diagnosis, no previous endocrine treatment and osseous metastases.

Original languageEnglish
Pages (from-to)460-465
Number of pages6
Issue number6
Publication statusPublished - 1993


  • Advanced breast cancer
  • Prognostic factors for response to chemotherapy
  • Time to response to chemotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Analysis of time to response to chemotherapy in 316 metastatic breast cancer patients'. Together they form a unique fingerprint.

Cite this